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Abstract
The purpose of the study was to examine whether psychosocial and spiritual well-being is associated
with African-American dialysis patients' end-of-life treatment preferences and acceptance of
potential outcomes of life sustaining treatment. Fifty-one African Americans with end stage renal
disease (ESRD) completed a socio-demographic questionnaire and interview with measures of
symptom distress, health-related quality of life, psychosocial and spiritual well-being, and
preferences and values related to life sustaining treatment choices. The subjects were stratified by
end-of-life treatment preferences and by acceptance of life sustaining treatment outcomes and
compared for psychosocial and spiritual well-being as well as socio-demographic and clinical
characteristics. Individuals who desired continued use of life sustaining treatment in terminal illness
or advanced dementia had significantly lower spiritual well-being (p = .012). Individuals who valued
four potential outcomes of life sustaining treatment as unacceptable showed a more positive, adaptive
well-being score in the spiritual dimension compared to the group who valued at least one outcome
as acceptable (p = .028). Religious involvement and importance of spirituality were not associated
with end-of-life treatment preferences and acceptance of treatment outcomes. African Americans
with ESRD expressed varied levels of psychosocial and spiritual well-being, and this characteristic
was associated with life sustaining treatment preferences. In future research, the assessment of
spirituality should not be limited to its intensity or degree but extended to other dimensions.
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Although studies have indicated that African Americans generally prefer more aggressive
treatment at the end of life than Caucasians 1-4, the characteristics of those who desire to delay
death with life sustaining measures have not been well described. Some experts hypothesize
that one of the reasons African Americans prefer life sustaining treatment more than do
Caucasian counterparts may be their strong religiosity or spirituality 5-11. However,
surprisingly little empirical evidence supports the theory that African-Americans' spirituality
influences their end-of-life preferences. Furthermore, in empirical studies, religiosity or
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spirituality typically has been assessed in a restrictive and simplified manner by asking
individuals' religious affiliation, degree of religiosity or spirituality, and the frequency of
religious involvement. These methodological approaches assume that religion or spirituality
vary only in intensity and do not have more complex effects or manifestations.
A recent study 11 examined the role of ethnicity and spiritual coping in cancer patients' end-
of-life treatment preferences and reported that African Americans were more likely to desire
life sustaining measures than were Caucasians. Among all study participants, belief in divine
intervention, turning to higher power for strength, support and guidance, and using spirituality
to cope with cancer were significantly associated with preference for CPR and life-sustaining
measures, but only at a modest level (r < .40). Spirituality in this study was assessed with
dimensions beyond what has been typically asked in other studies, and the study findings reflect
an association between individuals' spiritual coping style and their preferences for life
sustaining treatment.
This research raises further questions about how spiritual well-being within illness experience
is associated with African-Americans' views on life sustaining treatment. We explored this
question using the baseline interview data collected from African Americans with end-stage
renal disease (ESRD). The purposes of the study were 1) to examine differences in socio-
demographic and clinical characteristics and psychosocial-spiritual well-being between
African-American dialysis patients who would and who would not prefer comfort care only at
the end of life and 2) to determine whether psychosocial-spiritual well-being is associated with
their acceptance of potential outcomes of life sustaining treatment.
Methods
Sample and Setting
This study used the baseline interview data from 51 individuals who participated in a
randomized clinical trial of an end-of-life communication intervention, who met the following
inclusion criteria: 1) self-identified African American, 2) ≥ 18 years of age, and 3) receiving
dialysis for at least 3 months prior to the study enrollment. Subjects were recruited from five
dialysis clinics in western Pennsylvania. They were first approached by a social worker at the
dialysis clinic between January 2007 and January 2008. Those who indicated an interest in the
study were subsequently approached by the research staff for informed consent and a cognitive
function test, the 10-item Short Portable Mental Status Questionnaire (SPMSQ) 12. Patients
with ≤ 2 errors on the SPMSQ, indicating normal cognitive functioning, were eligible and
enrolled in the study after giving informed consent. Of 101 patients who deemed eligible and
initially approached, 1 failed SPMSQ and 49 refused to participate in the study. The study
procedures were approved by the University of Pittsburgh Institutional Review Board.
Instruments
Data were collected using a brief written questionnaire, a structured chart review and in-person
interview. The written socio-demographic questionnaire included data on age, gender,
education, marital status, employment status, annual household income, health insurance,
religious preference and involvement, and a single item asking the individual to rate the
importance of spirituality in life on a 4-point scale (from ‘not at all important’ to ‘extremely
important’). Clinical data collected by chart review included duration of dialysis and co-
morbidities using the modified Charlson Comorbidity Index (CCI). The CCI incorporates the
underlying illness condition for dialysis and other known predictors of complications, such as
age, albumin level, diabetes, and cardiovascular disease and has shown its usefulness as a
predictor of mortality in dialysis patients 13. Scores range from 2 to 14 with a higher score
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indicating a greater risk of mortality. Good inter-rater reliability for the index has been reported
(kappa = 0.93) in dialysis patients 14.
The in-person interviews included measures of symptom distress, health-related quality of life,
psychosocial-spiritual well-being, and preferences and values related to life sustaining
treatment choices. Symptom distress was assessed using the Dialysis Symptom Index (DSI),
which is comprised of 30 items that measure the presence (yes/no) of specific physical or
emotional symptoms experienced during the previous 7 days 15, 16. Each item is attached with
a 5-point Likert scale (1 = “not at all bothersome” to 5 = “bothered very much”) to assess the
distress of each symptom. The overall symptom burden score is computed by summing the
number of symptoms present (range 0 – 30). A total symptom distress score is calculated by
summing distress scores for individual symptoms (range 0 – 150). The scale's content validity
and test-retest reliability have been reported with African-American and Caucasian dialysis
patients (percent total agreement = 0.80, kappa = 0.48 – 0.90) 15. The SF12v2® Health Survey
was used to measure health-related quality of life based on 8 dimensions: physical functioning,
role physical, bodily pain, general health, vitality, social functioning, role emotional, and
mental health. Each dimension is scored using a norm-based method to have a mean of 50 and
a SD of 10 in the general U.S. population. These 8 scores are aggregated to compute two
standardized summary scores, Physical Component Summary (PCS) and Mental Component
Summary (MCS)17.
Psychosocial-spiritual well-being was measured using the 28-item Self-Perception and
Relationship Tool (S-PRT) 18. This instrument measures perceptions of the impact of illness
experience on physical and mental-emotional, social and spiritual dimensions. Each item is
scored with a 7-point semantic rating scale (+3 to -3) between word pairs. A mean score
between +1 and +2 indicates adaptive well-being with the current illness. The tool has
consistently shown good internal consistency (α ≥ 0.94), convergent and criterion-related
validities (0.49 - 0.67) in renal and cancer patients 18.
Specific items in the interview were used to clarify the patient's threshold for unacceptable
conditions/outcomes of life sustaining treatment. In our pilot study 19, four outcomes of life
sustaining treatment were chosen based on a comprehensive literature review and in-depth
interviews with 10 African Americans with ESRD who identified conditions that would be
unacceptable and considered worse than death. These items ask patients to imagine that they
develop cancer that has spread or has a severe stroke or heart attack and become seriously ill
at the hospital. Patients then were asked to think about conditions that for them would be worse
than death and they would want their family member to make a decision to stop life sustaining
treatment, including dialysis, and focus on treatment to make them as comfortable as possible.
Patients were presented with four outcomes and asked whether the outcome would be
“Acceptable”, “Not acceptable”, or “Unsure.” The outcomes of life sustaining treatment
include: cannot recognize my family or friends, only responding to pain and yet in untreatable
pain most of the time, can no longer control my bowels, and have to live in a nursing home
until death. Patients were encouraged to add any other conditions that were not addressed in
the four outcomes.
End of life treatment preferences were assessed using the Goals of Care document that presents
two scenarios describing medical conditions that commonly occur in patients with ESRD. The
first scenario describes a condition where the patient develops cancer that spreads or severe
complications and cannot speak for him/herself. The medical team believes that he/she is
unlikely to recover and that continuing life sustaining treatment, including dialysis, is no longer
beneficial to him/her. The second scenario describes a condition where the patient develops
advanced dementia and he/she can no longer be him/herself. His/her dementia is no longer
responding to treatment. For each scenario, patients choose one of three options, “the goals of
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care should be focused on delaying my death, and thus I want to continue life sustaining
treatment”, “the goals of care should be focused on my comfort and peace, and thus I do not
want life sustaining treatment, including dialysis”, and “I am not sure”.
Data Analysis
Descriptive statistics were used to summarize the sample characteristics. The subjects'
responses were stratified by end of life treatment preferences (comfort care only in both
scenarios, continue use of dialysis in both scenarios, or mixed preferences). Responses were
also stratified by how they valued four potential life sustaining treatment outcomes
(unacceptable for all four outcomes vs. acceptable for at least one outcome). Non-parametric
tests (χ2-test Fisher's exact test, or Mann Whitney U test as appropriate) were used to examine
group differences in socio-demographic and clinical characteristics. To test the hypotheses,
whether psychosocial and spiritual well-being differs by end-of-life preferences and by values
of life sustaining treatment outcomes, permutation tests were used with Monte Carlo estimation
procedures 20-23. Permutation tests are a resampling approach and are particularly useful for
statistics based on small samples where asymptotics do not work properly 20. The procedures
began with computing a test statistic (either t or F as appropriate) for the data. Second, the data
were permuted (rearranged) repeatedly. The number of repetitions was 10,000 based on
Lunneborg's formula 24. Third, the test statistic was computed for each of the resulting data
permutations. Those data permutations, including the one representing the obtained results,
comprise the reference set for determining significance. Fourth, the significance or probability
value was computed. The proportion of data permutations in the reference set that have test
statistic values greater than or equal to (or less than or equal to) the value for the observed
results was the p-value.
Results
Sample Characteristics
Table 1 presents the characteristics of the overall sample and the three groups stratified by their
end-of-life treatment preferences in two clinical scenarios. The mean age of the overall sample
was 58 and roughly half of subjects were male. Seven patients completed less than high school
education. Over 90% (n = 47) of the sample were retired or disabled. Seventeen (33.3%) were
currently married or living with a significant other and 12 (23.5%) were never married. The
patients were undergoing dialysis treatment for nearly 4 years on average. The mean of CCI
was 6.18, a high score suggesting a 27% of one year mortality rate 25. The patients were
experiencing a total of 13 symptoms currently. The mean PCS of SF12 (SD) was 34.13 (9.95),
which is somewhat worse physical health related quality of life than 50th percentile for the US
kidney disease population 17. However, the mean MCS (SD) was 49.03 (12.72), which is
somewhat higher mental health related quality of life than 50th percentile for the U.S. kidney
disease population of a similar age (= 44.82). Of the 51 subjects, two patients were listed on
the kidney transplant candidate list at the time of study participation. All subjects had a durable
power of attorney for health care document in their medical charts. However, it was unknown
whether they had a living will because having an advance directive was not an inclusion
criterion.
Religiosity and Spirituality Variables and Psychosocial-Spiritual Well-Being
Sixty-five percent of the total sample responded that they followed religious customs and
practices frequently or always and 61% reported spirituality is extremely important in their
lives. The social and spiritual well-being scores (≥ 1.0) in the total sample indicated a positive,
adaptive well-being in those dimensions. The mental-emotional well-being scores (M = .88)
reflect the subjects' less than optimal emotional well-being.
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End-of-Life Treatment Preferences and Values of the Life Sustaining Treatment Outcomes
Of the 51 participants, 27 selected comfort care for both scenarios of terminal illness and
advanced dementia, 11 selected continued use of dialysis and other forms of life sustaining
treatment in both scenarios, and 13 had mixed preferences. Seventeen (33.3%) responded all
four outcomes of life-sustaining treatment presented were unacceptable. The outcome endorsed
as unacceptable most often was If I can no longer control my bowels (n = 41, 80.4%) followed
by If I am only responding to pain and yet in untreatable pain most of the time (n = 38, 74.5%)
and If I cannot recognize my family or friends (n = 34, 66.7%). A half of the sample (n = 25)
found the outcome, If I have to live in a nursing home until death after surviving
hospitalization, to be unacceptable.
Associations of the Socio-demographic and Clinical Characteristics with End-of-Life
Treatment Preferences and Values of the Life Sustaining Treatment Outcomes
There were no significant differences among the three groups stratified by the end-of-life
treatment preferences in socio-demographic and clinical characteristics. Religious
involvement and importance of spirituality were not associated with those treatment
preferences. Similarly, socio-demographic and clinical characteristics as well as religious
involvement and importance of spirituality did not significantly differ between the two groups
stratified by the values of the life sustaining treatment outcomes.
End-of-life Treatment Preferences, Values of the Life-Sustaining Treatment Outcomes and
Psychosocial-Spiritual Well-Being
Spiritual well-being was associated with participants' choices in goals of care in end-of-life
scenarios. Likewise, spiritual well-being was associated with their willingness to accept
potential poor health outcomes from life-sustaining treatments. Individuals who desired
continued use of life-sustaining treatment in both scenarios of terminal illness and advanced
dementia had significantly lower spiritual well-being compared to those favoring comfort care
in one or both scenarios (obtained F = 4.83, p = 0.012) (Table 1). Similarly, the group endorsing
all four poor health outcomes as unacceptable showed a more positive, adaptive well-being
score in the spiritual dimension (obtained t = 2.17, p = .028) compared to the group endorsing
at least one outcome acceptable. (Table 2)
Discussion
This study is the first to examine spiritual well-being as a dimension of religious and spiritual
influences on clinical treatment choices. In a group of African Americans with ESRD on
dialysis, we found that greater spiritual well-being characterized those individuals who would
choose comfort care only if faced with terminal cancer or advanced dementia. Individuals with
higher spiritual well-being also expressed a greater tendency to stop life sustaining treatments
if faced with 4 adverse health outcomes. Notably, common assessments of religious practices
and importance of spirituality were not associated with these preferences or values. These
findings indicate that the intensity of religious or spiritual expression may not explain African-
Americans' preference for more use of life sustaining treatment. Rather, those with better
spiritual well-being may be more willing to forgo life sustaining treatment, while those who
do not derive a sense of well-being from spiritual sources of support may be less willing to do
so. This result may appear counter-intuitive or contradictory to the current literature. However,
it is important to note the conceptual distinction among religiosity, spirituality, and spiritual
well-being. Religiosity or religiousness often refers to the various organized, individual, and
attitudinal manifestations of different faith tradition 26. Spirituality refers to the individual's
personal experience, commonly seen as connected to some formal religion but increasingly
viewed as independent of any organized religion 27, 28. Spiritual well-being is defined as a
sense of harmonious interconnectedness between self and others or a transcendent being and
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achieved through an integrative growth process that leads to a realization of the ultimate
purpose and meaning of life 29. These three constructs are related but distinctive, and it is
possible that people with strong religiosity or spirituality may not necessarily be in high
spiritual well-being, particularly in a time of illness or suffering. In this study, the majority of
the sample endorsed a high degree of religious involvement and the importance of spirituality
in life, yet the level of spiritual well-being varied. Furthermore, the correlations of religious
involvement and the importance of spirituality in life with spiritual well-being were modest (r
< .45).
The findings that spiritual well-being, not the degree of religiousness or spirituality, are
correlated with African-Americans' preferences and values underscore the importance of
exploring end-of-life preferences and values in the context of individuals' illness experiences.
Previous studies indicated that patients with ESRD experience severe burden of illness and
existential suffering (e.g., questioning life on life support) during the course of illness 30, 31.
Therefore, other dimensions of spirituality should be assessed in order to better understand
what mediates the relationship between spirituality and end-of-life treatment preferences. Our
findings also suggest that African American dialysis patients who report strong religiosity and
spirituality may have varying level of spiritual well-being and may express differing end-of-
life treatment preferences and values than the existing, common belief that they would prefer
aggressive treatment at end of life. This is important knowledge for health care providers as
they are facing increasing responsibility for spiritual care for those with serious illness 32-36,
37.
The four outcomes of life sustaining measures used in this study were selected based on
interviews with a group of African Americans dialysis patients who had similar characteristics
of the study sample. Although others also used scenarios reflecting values of treatment
outcomes to understand treatment preferences of serious ill patients 38-40, our approach to
assessing African American dialysis patients' acceptance of potential outcomes of life
sustaining measures differs in that the four treatment outcomes were drawn from the members
of the study patient population and individual responses to the outcomes reveal their unique
values as shown in the results. Again, that these values were significantly associated with
spiritual well-being enhances our understanding of factors influencing end-of-life treatment
preferences and values.
Conclusions drawn from our findings are preliminary, given study limitations. First, our sample
size is small although it was determined based on a number of subjects required for the original
clinical trial of an end-of-life communication intervention. Although the sample appeared to
be similar to African Americans in the national dialysis population 41, our sample was
somewhat younger and consisted of patients who met our specific inclusion criteria. Therefore,
our study findings may not be generalizable to a lager patient group. Secondly, the study
included solely dialysis patients without comparison groups of African Americans with other
serious illness and thus caution is needed for interpreting the results.
Although religiosity or religion may provide intellectual, behavioral and social form to spiritual
expression 42, 43, the common assessment of spirituality has been limited to degree/intensity
of spirituality or the frequency of religious involvement. However, several studies revealed
that spirituality provides African Americans with guidance and hope and is a major resource
for adjustment to and coping with serious illness 44-46. Religion and spirituality are complex
and heterogeneous aspects of the human experience. Variation in intensity of belief alone is
unlikely to represent individual differences in interpretation of health and healing in
relationship with spiritual belief. Future research should include the assessment of other
dimensions of spirituality rather than a simplified measure of intensity in order to explore how
spirituality manifests and contributes to African-Americans' treatment preferences and values.
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Table 1
End-of-Life Treatment Preferences by Sample Characteristics














 Age 57.78 ± 13.18 52.91 ± 14/66 62.15 ± 13.50 57.67 ± 12.14
 Male 29 (56.90) 7 (63.64) 8 (61.54) 14 (51.85)
 Female 22 (43.10) 4 (36.36) 5 (38.46) 13 (48.15)
 Currently married 15 (29.40) 3 (27.30) 2 (15.40) 10 (37.00)
 Disabled/unable to work 30 (58.80) 11 (100.0) 8 (61.5) 11 (40.70)
 Education in year 13.63 ± 2.68 13.82 ± 2.93 12.85 ± 1.77 13.93 ± 2.95
 Annual household income
  < $13,000 23 (45.10) 7 (63.64) 6 (46.15) 10 (37.04)
  ≥ $13,000 28 (54.90) 4 (36.36) 7 (53.85) 17 (62.96)
Clinical
 Duration of dialysis in month 47.77 ± 49.22 45.68 ± 51.69 53.35 ± 55.31 45.94 ± 46.89
 CCI 6.18 ± 2.49 4.91 ± 1.97 7.00 ± 2.83 6.30 ± 2.38
 Dialysis Symptom Distress 40.96 ± 24.68 39.09 ± 30.43 41.92 ± 24.38 41.26 ± 23.21
 SF12v2, PCS 34.14 ± 9.95 35.84 ± 9.52 28.98 ± 7.85 35.92 ± 10.45
  MCS 49.03 ± 12.72 45.88 ± 11.62 51.01 ± 11.78 49.36 ± 13.75
Religious custom and Psychosocial-
spiritual
 Extent of following religious customs
and practices
  Never or sometimes 18 (35.29) 5 (45.45) 3 (23.08) 10 (37.04)
  Frequently or always 33 (64.71) 6 (54.55) 10 (76.92) 17 (62.96)
 Importance of spirituality in life
  < Extremely 20 (39.22) 5 (45.45) 5 (38.46) 10 (37.04)
  Extremely 31 (60.78) 6 (54.55) 8 (61.54) 17 (62.96)
 Psychosocial-Spiritual Well-Being
  Mental-Emotionala .88 ± 1.12 .95 ± 1.26 1.20 ± 1.26 .69 ± .99
  Socialb 1.91 ± 1.11 1.51 ± 1.49 2.04 ± .97 2.01 ± 1.0
  Spiritual* 1.53 ± 1.32 .51 ± 1.76 1.88 ± 1.16 1.77 ± .98
a
F = .926, p = .40; p values are based on permutation tests.
b
F = .929, p = .41; p values are based on permutation tests.
*
F = 4.830, p = .012; p values are based on permutation tests.
CCI: Charlson Comorbidity Index, PCS: Physical Component Summary, MCS: Mental Component Summary.
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Table 2
Acceptance of Outcomes of Life-Sustaining Treatment by Religious Involvement, Important of Spirituality and
Psychosocial-Spiritual Well-Being
Dimension
“Unacceptable” for All 4
Outcomes
(n = 17)
“Acceptable” for At Least One
Outcome
(n = 34)
Extent of following religious customs and practices, n (%)
 Never or sometimes (n = 18) 7 (41.18) 11 (32.35)
 Frequently or always (n = 33) 10 (58.82) 23 (67.66)
Importance of spirituality in life
 < Extremely (n = 20) 7 (41.18) 13 (38.24)
 Extremely (n = 31) 10 (58.82) 21 (61.76)
Psychosocial-Spiritual Well-Being
Dimensions, M ± SD
 Mental-Emotionala .66 ± 1.00 .99 ± 1.18
 Socialb 2.29 ± .82 1.72 ± 1.20
 Spiritual* 2.03 ± 1.02 1.28 ± 1.39
a
t = .98, p = .41; p values are based on permutation tests.
b
t = 1.78, p = .08; p values are based on permutation tests.
*
t = 2.17, p = .043; p values are based on permutation tests.
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